No Data
No Data
Express News | Altamira Therapeutics Highlights Review Article Published On Use Of Betahistine In Vertigo Management
Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management
Hamilton, Bermuda, June 20, 2024 (GLOBE NEWSWIRE) -- Independent review discusses evidence supporting the use of betahistine to alleviate residual dizziness following physical repositioning procedur
Express News | Altamira Therapeutics Ltd - Merged Entity Will Be Called Altamira Therapeutics AG and Continue to Serve as Core Operating Subsidiary of Company
Express News | Altamira Therapeutics Provides Business Update On RNA Delivery Platform; Announces Improvement In RNA Nanoparticle Stability, Pursues Partnering Opportunities For AM-125 In Vertigo And CNS Indications, And Switches Financial Reporting From Swiss...
Express News | Altamira Therapeutics Ltd - Co Is About to Merge Two of Its Subsidiaries in Basel (Switzerland), Auris Medical AG and Altamira Therapeutics AG
Express News | Altamira Therapeutics Ltd - Streamlining Corporate Structure; Switch in Financial Reporting From Swiss Francs to US Dollars
No Data